Prevalence of Ischemic Brain Injury in Neonates With Congenital Heart Disease: A Systematic Review and Meta-Analysis

Caroline Kim1, Devin Chetan2, Vanna Kazazian3

  • 1Department of Pediatrics, University of British Columbia and BC Children's Hospital Research Institute, Vancouver, Canada.

Neurology
|January 9, 2026
PubMed

Insights

Infants with critical congenital heart disease (CHD) have a high prevalence of ischemic brain injury, affecting over 68%. Early identification is crucial for neurodevelopmental outcomes and interventions.

Area of Science:

  • Neonatal Neurology
  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics

Background:

  • Infants with critical congenital heart disease (CHD) face elevated risks of brain injury and neurodevelopmental impairments.
  • Existing studies report variable rates of ischemic brain injury in this vulnerable population.

Purpose of the Study:

  • To systematically review and meta-analyze the prevalence of ischemic brain injury in neonates with critical CHD.
  • To identify associated risk factors for brain injury in these infants.

Main Methods:

  • Systematic review and meta-analysis of original research studies published up to 2024.
  • Inclusion of studies reporting ischemic brain injury prevalence in neonates with critical CHD; exclusion of case reports.
  • Assessment of bias using Newcastle-Ottawa Scale and revised Cochrane risk-of-bias tool; pooled prevalence calculated using random-effects models.

Main Results:

  • A pooled cumulative prevalence of ischemic brain injury was found to be 68.5% in neonates with critical CHD.
  • Preoperative ischemic brain injury prevalence was 34.7%, while new postoperative ischemic brain injury was 46.5%.
  • Age at surgery and proportion of female sex were associated with white matter injury and arterial ischemic stroke, respectively.

Conclusions:

  • Ischemic brain injury is highly prevalent in neonates with critical CHD, varying by injury type and timing.
  • Identifying these injuries is vital for family counseling on neurodevelopmental outcomes and initiating early surveillance.
  • Further research is needed to identify modifiable risk factors and neuroprotective strategies due to literature heterogeneity.
Abstract